Roth Capital Partners has appointed Michael Margolis as head of healthcare investment banking. Mr. Margolis has been a managing director at the firm since 2010.
Titan Pharmaceuticals (NASDAQ:TTNP), in a move to boost its product development and commercialization experience in the U.S., Europe and Asia, named Scott Smith and Dr. Rajinder Kumar to its board.
Cantor Fitzgerald has expanded its healthcare equity research team with the addition of Bill Tanner as a senior research analyst covering biotechnology and Steven Halper as a senior research analyst covering healthcare...
3D Signatures (TSX-V:DXD) named Helen Stevenson to the board and Ian Smith, who is stepping down from the board, to the clinical and scientific advisory board (CSAB).
3D Signatures (TSX-V:DXD) has appointed Nigel Terrett to 3DS's business advisory board to provide the company with strategic insight and guidance related to commercial lab partnerships and information technology...
Jeff Sacher has joined Aegis Capital to lead the firm's global healthcare effort as a managing director.Previously, Mr. Sacher was a senior banker at Goldman Sachs, Needham and Brean Capital. In addition, he has served...
Microbix Biosystems (TSX:MBX) appointed Jim Currie as CFO, succeeding Charles Wallace, who is retiring at the end of the year.Mr. Currie was most recently CFO of SMTC, a global electronics manufacturing services company...